A freshly-launched webinar series from the Rare Disease Cures Accelerator–Data and Analytics Platform (RDCA-DAP®) reports how person-level data influences drug development and regulatory decision-making. Each 1-hour webinar features how person-level RWD has been used in drug development for an individual rare disease. A panel of quantitative and regulatory experts discusses the lessons learned from each approach at the end of every presentation.
According to speaker Jeff Barrett, “We’re excited to kick off this first webinar as evidence we are indeed extending our outreach to partners globally and looking for strong collaboration with expertise around the world. And our relationship with Clinerion, we have had an MOU in place for some time now. This is a key partner for us and the strategic alliance we’re expecting to bear fruit for the entire rare disease ecosystem.”
Catch the webinar series by clicking here.
(Source: Clinerion, October 27th, 2021)